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Background:  Barlow’s disease or classic mitral valve prolapse (BMVP) and fibroelastic deficiency (FED) are 2 common forms of degenerative 
mitral valve disease (MVD). Epidemiologic data suggest genetic underpinnings of BMVP with identification of genetic polymorphisms and associated 
anthropometric changes. Whether a distinct lipoprotein pattern coexists among pts with BMVP is not known.
Methods:  Ninety pts with MVD were compared with 90 healthy controls (matched for age, gender, body mass index). Among the 90 MVD pts, 41 
had BMVP and 49 had FED determined echocardiographically. Multivariable linear regression analysis was used to study associations between MVD 
type and lipoprotein levels, adjusted for gender, statin use and alcohol use.
Results:  As compared to FED pts and controls, those with BMVP had a lower body mass index and prevalence of coronary disease, while having 
higher HDL cholesterol levels (Table). The distinct pattern of an HDL level >70 mg/dl was noted in 49% BMVP pts vs. 6% FED vs. 28% controls 
(among males only, 28% BMVP vs. 5% FED; p=0.027). In multivariable analysis, BMVP was associated with higher HDL levels compared to FED pts 
and controls (p<0.0001).
Conclusions:  In this initial study examining the association between lipoprotein levels and degenerative MVD, a distinct pattern of unusually high 
HDL levels was seen among pts with Barlow’s disease, suggesting a possible genetic linkage.
Characteristics and Lipid Profiles of MVD Patients
Characteristic
Barlow’s MVP 
(n=41)
Fibroelastic Deficiency 
(n=49)
Healthy Controls 
(n=90)
P value (BMVP vs. 
FED)
P value (BMVP vs. 
Controls)
Age, years ± SD 61 ± 14 66 ± 16 64 ± 16 0.1 0.4
Male gender, (%) 44 80 62 <0.001 0.05
Body mass index, kg/m2 23 ± 3 26 ± 4 25 ± 4 <0.001 <0.001
LDL-c, mg/dl 107 ± 28 103 ± 28 112 ± 38 0.5 0.5
Triglycerides, mg/dl 91 ± 40 118 ± 65 122 ± 69 0.02 0.008
HDL-c, mg/dl 71 ± 19 51 ± 12 58 ± 17 <0.001 <0.001
Coronary disease, % 10 31 0 0.01 0.002
